National Institutes of Health
Exposomic Contributions to ADRD Pathology and Resilience
Exposomic Contributions to ADRD Pathology and Resilience is a funding opportunity from National Institutes of Health, closing October 5, 2026.
Oct 5, 2026
(66d left)Overview
The National Institute of Neurological Disorders and Stroke (NINDS) is interested in supporting research projects that investigate how specific neural exposome factors contribute mechanistically to Alzheimer’s disease-related dementias (ADRD) pathology and resilience. For the purposes of this program, exposome…